Watch Ticker

Astria Therapeutics, Inc. Common Stock

Go to Astria Therapeutics, Inc. Common Stock Website

$6.89

0.33 (5.03%)

Live

Previous Close

$6.89

Day Range

$6.47 - $6.93

Previous Day Range

$6.52 - $6.86

Market Cap

$370.2 million USD

Day Vol.

365570

Previous Day Vol.

233466

Currency

USD

Primary Exchange

Nasdaq

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of pla...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Angioedema Clinical Trial Pipeline Analysis Demonstrates 15+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

The angioedema treatment market is expected to grow due to the rising prevalence of allergic conditions and increasing awareness of hereditary angioedema (HAE). The pipeline analysis shows over 15 companies are developing 20+ angioedema drugs, with promising therapies in different clinical trial phases.

Related tickers: IONS, ATXS, NTLA, KALV, CAMP.

Read Full Article

Zacks Equity Research - Is Artivion (AORT) Stock Outpacing Its Medical Peers This Year?

Here is how Artivion (AORT) and Astria Therapeutics, Inc. (ATXS) have performed compared to their sector so far this year.

Related tickers: AORT, ATXS.

Read Full Article

Trending Tickers

Please sign in to view